Lymphatic filariasis laboratory findings

Jump to navigation Jump to search

Lymphatic filariasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Lymphatic Filariasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphatic filariasis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphatic filariasis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphatic filariasis laboratory findings

CDC on Lymphatic filariasis laboratory findings

Lymphatic filariasis laboratory findings in the news

Blogs on Lymphatic filariasis laboratory findings

Directions to Hospitals Treating Lymphatic filariasis

Risk calculators and risk factors for Lymphatic filariasis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]

Laboratory Findings

  • The standard method for diagnosing active infection is the identification of microfilariae in a blood smear by microscopic examination. The microfilariae that cause lymphatic filariasis circulate in the blood at night (called nocturnal periodicity). Blood collection should be done at night to coincide with the appearance of the microfilariae, and a thick smear should be made and stained with Giemsa or hematoxylin and eosin. For increased sensitivity, concentration techniques can be used.
  • Because lymphedema may develop many years after infection, lab tests are most likely to be negative with these patients.
  • The eosinophilia is often accompanied by high levels of IgE (Immunoglobulin E) and antifilarial antibodies.

References

Template:WH Template:WS